Articles with "rhamm" as a keyword



Photo by goian from unsplash

The Pro-fibrotic Response of Mesenchymal Leader Cells to Lens Wounding Involves Hyaluronic Acid, Its Receptor RHAMM, and Vimentin

Sign Up to like & get
recommendations!
Published in 2022 at "Frontiers in Cell and Developmental Biology"

DOI: 10.3389/fcell.2022.862423

Abstract: Hyaluronic Acid/Hyaluronan (HA) is a major component of the provisional matrix deposited by cells post-wounding with roles both in regulating cell migration to repair a wound and in promoting a fibrotic outcome to wounding. Both… read more here.

Keywords: post; rhamm; mesenchymal leader; leader ... See more keywords
Photo from wikipedia

The role of RHAMM in cancer: Exposing novel therapeutic vulnerabilities

Sign Up to like & get
recommendations!
Published in 2022 at "Frontiers in Oncology"

DOI: 10.3389/fonc.2022.982231

Abstract: Receptor for hyaluronic acid-mediated motility (RHAMM) is a cell surface receptor for hyaluronic acid that is critical for cell migration and a cell cycle protein involved in microtubule assembly and stability. These functions of RHAMM… read more here.

Keywords: rhamm; rhamm cancer; cancer exposing; role rhamm ... See more keywords
Photo by ospanali from unsplash

Tumor-Tissue Expression of the Hyaluronic Acid Receptor RHAMM Predicts Histological Transformation in Follicular Lymphoma Patients

Sign Up to like & get
recommendations!
Published in 2022 at "Cancers"

DOI: 10.3390/cancers14051316

Abstract: Simple Summary Histological transformation remains the leading cause of death in patients diagnosed with follicular lymphoma (FL). To date, no clinical nor biological biomarkers have been identified to unequivocally predict patients in high risk of… read more here.

Keywords: rhamm; expression; follicular lymphoma; hyaluronic acid ... See more keywords

Redox Responsive Hyaluronic Acid Nanogels for Treating RHAMM (CD168) Over-expressive Cancer, both Primary and Metastatic Tumors

Sign Up to like & get
recommendations!
Published in 2017 at "Theranostics"

DOI: 10.7150/thno.18340

Abstract: It remains a substantial challenge to targetedly deliver drug to both primary tumors and metastatic lesions employing a single nanoparticle delivery system. Here aiming at the receptor for hyaluronic acid mediated motility (RHAMM or CD168),… read more here.

Keywords: drug; rhamm; primary metastatic; hyaluronic acid ... See more keywords